Overview
Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)
Description
The present prospective national study aims to provide a description of the population affected by ES, an insight into the natural history of the disease and an answer some on the outstanding questions on its management. Also, it will focus on enhancing any differences between the two ES variants (classical-type and proximal-type) in order gain a better understanding of the disease, tailor the treatment and lastly improve outcome.
Eligibility
Inclusion criteria
- Histological diagnosis of epithelioid sarcoma according to 2014 World Health Organization (WHO) classification, performed on biopsy or surgical specimen
- Signed informed consent
- Adequate patient compliance to treatment or follow up
- No age limit
Exclusion criteria
- Other malignancies within past 5 years, with exception of carcinoma in situ of the cervix and basocellular skin cancers treated with eradicating intent
- Impossibility to ensure adequate compliance